Making Crack With Levamisole For Fish
A granulocytosis can kill you, but its symptoms are frustratingly broad. Some people's throats close up. Some people get diarrhea. Some people get skin infections, sores in their mouth or anus, or just a fever. Some people have it, don't know it, and get better without seeing a doctor. Some people don't see a doctor until it's too late. Basically, agranulocytosis is a catastrophic crash in a person's immune system, which can turn a zit, a scratch, or even the bacteria that normally live in and around your body into a life-threatening infection.
In one vividly described case from the 1920s, an otherwise healthy 40-year-old woman came down with a mysterious fever. Over the next nine days, under the care of baffled physicians, she sprouted 'brownish papular eruptions' all over her face and body, necrotic abscesses on her neck and buttocks, and 'a greyish-green dirty membrane' covering her mouth and throat with 'scattered small greyish ulcers.' In one cubic millimeter of blood, her doctors found 4,000,000 red blood cells but only 1,000 white blood cells.
Then, after a blood transfusion, she died. Agranulocytosis is rare and typically caused by medications: Antibiotics, gold salts (to treat arthritis), and some antipsychotic drugs can trigger the crash. But lately, doctors have been seeing more and more cocaine users with mysterious cases of agranulocytosis linked to a mysterious cutting agent called levamisole. Levamisole was discovered in 1966 and studied for its ability to rev up the effects of chemotherapy drugs and people's immune systems. It also turned out to work wonders with intestinal worms. Levamisole is an immunomodulator, meaning it can either strengthen or weaken your immune system, depending on your genes and what other drugs you might be taking.
But too many patients came down with agranulocytosis, the studies were discontinued, and the FDA withdrew its approval of the drug. One of the last studies on levamisole use in humans was in 2001, when Iranian researchers gave the drug to a group of girls who lived in crowded, unhygienic conditions with uncontrollable lice infestations. According to the International Journal of Dermatology, a 10-day course of levamisole tablets was 'completely effective': The girls took the drugs, and the drugs poisoned the lice. (The study didn't mention whether the drugs poisoned the girls.) These days, levamisole is mostly used by farmers to deworm cows and pigs—and, for some reason, it's also used by people in the cocaine trade.
The DEA first reported seeing significant amounts of levamisole-tainted cocaine in 2005, with 331 samples testing positive. Then the numbers spiked: The DEA found 6,061 tainted samples in 2008 and 7,427 in 2009. One DEA brief from 2010 reports that between October 2007 and October 2009, the percentage of seized cocaine bricks containing levamisole jumped from 2 percent to 71 percent. Which is not only sudden, but odd. Levamisole is not like other common cutting agents—sugar, baking powder, laxatives, etc.—in three important ways: 1. It's more expensive than other cuts. It makes some customers sick.
It's being cut into the cocaine before it hits the United States. This last mystery is the most puzzling. Typically, smugglers like to move the purest possible product—less volume means less chance of detection—and cut their drugs once they cross into the United States. So what's the incentive to use a relatively expensive cut of something that makes your customers sick and increases your smuggling risk? Even stranger: The cocaine trade, in both smuggling and production, has fragmented in recent years (more on that in a minute). If there's no central production, how did hundreds and hundreds of independent shops come to use the same unusual cutting agent? Nobody seems to know, including experts I spoke with on both coasts of the United States: doctors, scholars, chemists, think-tank fellows, research scientists, federal and state public-health analysts, law enforcement agencies from the Seattle Police Department to the DEA, and even people who work in and around the drug trade.
Everyone has theories, but nobody has answers. It's a mystery.
During levamisole's early clinical trials for cancer and autoimmune disorders, around 10 percent of the patients developed agranulocytosis. If the nation's cocaine supply is so thoroughly tainted, why aren't 10 percent of cocaine users going to hospitals with unexplained infections? 'Maybe 10 percent are experiencing pressure on their neutrophils,' says Dr. Phillip Coffin of the University of Washington, who has studied drug use in New York City and Seattle. (Neutrophils are the type of white blood cell wiped out by agranulocytosis.) 'But only a proportion of them are getting sick enough and using enough that they come to our attention. And an even smaller proportion of those people are coming to the attention of physicians who are aware of the cocaine-levamisole problem. There are many steps in the pathway that have left such a small number of cases being reported.'
The problem might be—and probably is—larger than we know. And, because of budget crunches, last month the CDC abandoned its surveillance program in Washington State.
This is worrisome not only for people who've already gotten sick and are likely to get sick again (doctors at Harborview have reported seeing the same patients multiple times for agranulocytosis), but because levamisole has a cumulative effect: The more you're exposed to it, the more likely you are to get sick, and even if you've had levamisole-tainted cocaine and not gotten sick doesn't mean you won't get sick from levamisole-tainted cocaine in the future. With the DEA reporting such a radical increase in the percentage of tainted cocaine (which more than doubled between 2008 and 2009), the number of people at risk is also increasing radically. The Test-Your-Own Kit Because the official research on levamisole's effects on human beings was stopped years ago—and, apart from Dr. Clark's pending experiments with rats, there's been no official research on its effects when combined with cocaine—there's still a lot we don't know. It's possible that agranulocytosis is only one of its health hazards. According to a 2009 article in the Journal of Analytic Toxicology, levamisole-laced cocaine might also increase the risk of cardiac problems: 'Cocaine increases sympathetic activity by blocking the reuptake of norepinephrine at the postganglionic synapse.
Additive, if not synergistic effects could be expected when the drugs are combined. Concerns of increased toxicity with exaggerated pressure response or development of arrhythmia could then arise when cocaine is combined with levamisole.' Heart attack and cardiac arrest are two of the common causes of death associated with cocaine overdoses—levamisole might exacerbate those risks. It's hard to say: Cocaine, according to the latest Seattle/King County drug trends report, released this June, is the most common illegal drug detected in deaths, but its manner of killing is less clear-cut than opiates.
'Opiate overdose is pretty simple and straightforward,' explains Dr. 'It's breathing.
Keep them breathing and they live. Cocaine is more difficult: Is it a massive heart attack?
Is it a stroke? It's not very well defined.' Currently, people who suffer cardiac problems associated with cocaine are not tested for the presence of levamisole, so we really have no idea what kind of damage this new cutting agent is inflicting on the nation's cocaine users, nor the strain on already strapped public funds—every time someone without health insurance lands in the emergency room, it costs taxpayers thousands of dollars. The fuzziness surrounding cocaine's destructive qualities makes harm-reduction strategies more difficult for cocaine than for opiates. Nobody doubts that cocaine is destructive. 'It's toxic to heart-muscle cells,' Dr. 'Even in its purest form, it's among the worst recreational drugs for the cardiovascular system.'
But its spectrum of harmful qualities, some of which are exacerbated by levamisole, makes it tricky to pinpoint good maintenance programs for chronic addicts. Opiate addicts, Dr. Coffin says, can live on methadone or other controlled dosing mechanisms their entire lives with no medical harm besides constipation and loss of libido. But cocaine- and amphetamine-maintenance programs haven't shown any conclusive results, despite attempts in Colombia to prescribe coca tablets and tea to addicts. One thing that can be done: develop an inexpensive field-test kit to try to detect levamisole. Clark has invented such a kit and—in association with The Stranger, a few folks in the local harm-reduction community, and the People's Harm Reduction Alliance (PHRA), which runs the U-District needle exchange—hopes to begin distributing kits in a few weeks. Unfortunately, kits are technically drug paraphernalia under Washington State law, not only because the kits will contain cocaine residue, but because it is illegal for any person to possess something used to 'process, prepare, test, analyze, pack, repack, store, contain, conceal, inject, ingest, inhale, or otherwise introduce into the human body a controlled substance.'
It's a perfect example of how drug prohibition laws make drugs more dangerous—an unregulated market for cocaine, with no quality control, has encouraged the use of levamisole as a cutting agent. Drug laws make it illegal for users to test their cocaine for poison—if users could, they might stop buying from dealers who sell tainted cocaine, putting economic pressure on the market to be less dangerous. It's a classically self-defeating chain of policies, but some antidrug warriors defend it on the grounds that since drugs are illegal, users get what they deserve. And if cocaine is perceived as more dangerous, perhaps fewer people will use it. This, of course, is a cruel, stupid, and expensive way to deal with the problem.
Clark put it: 'The idea of letting addicts die to make drugs scarier is reprehensible.' It's not quite the same in the heroin world: Because of the public outcry about the health risks of sharing needles, hypodermic syringes have a special exemption. Crack users need similar exemptions. 'If you read the paraphernalia laws, cocaine is both the forgotten drug and in some ways the most hated drug,' says Shiloh Murphy, director of PHRA, an independent nonprofit that isn't affiliated with public-health-funded needle exchanges.
He gestures behind him to a tower of cardboard boxes full of hypodermic needles. 'A young person just starting to inject knows he shouldn't share his syringes,' he says. 'But a 20-year crack veteran doesn't realize that every time he smokes and burns his lips and passes on his stem, he could be transferring the same diseases—it's open sores to open sores.' To combat this problem, Murphy has begun a controversial program to distribute crack stems, rubber crack 'condoms,' and fresh steel wool to users. (Steel wool, which is used as a filter in crack pipes, weakens and flakes off after repeated use, sending red-hot chunks of metal into users' throats and lungs, which leads to infections and abscesses.) Murphy got the idea for his crack program one afternoon two years ago, when he was approached by an angry crack user.
'I was sitting at the table, handing out flyers and things,' Murphy says, 'and a man said to me: 'You're a real motherfucker, you know that? You're sitting here with all these syringes and talking about health. I use crack and my friends are dying of HIV and hepatitis C and there's nothing on this table for us. I guess crack users are always just left to die.' I said, 'You're right. Tell me what you need.'
Levamisole Powder
It was an enlightening moment for me.' 'All we have to do,' he says, 'is save one person from getting HIV, and we've become economically worth it.' PHRA's annual budget is around $385,000. Its budget for the crack program is currently $6,000. The lifetime cost for the state to take care of an uninsured person with HIV, he says, is half a million dollars. 'We've saved the state thousands and thousands of dollars.' Now Murphy will be at the forefront of our combined attempt to distribute Dr.
Clark's levamisole kits to cocaine users. The kits will contain instructions for use, a fact sheet about levamisole and agranulocytosis, and a survey on a prestamped postcard about where and when the cocaine was purchased, whether it's powder or rock cocaine, whether it tested positive for levamisole, and a few other research questions.
Hopefully, that data will help us—me, Dr. Clark, PHRA, and a local harm-reduction organization called DanceSafe—develop a better understanding of how levamisole-tainted cocaine is distributed through the city and whether some neighborhoods face greater health risks than others.
(Is the cocaine you can buy on the street in Georgetown, for example, more or less tainted than the cocaine at some millionaire's house party in Bellevue?) As for its illegality: After a meeting with ACLU lawyer Alison Holcomb, Stranger publisher Tim Keck, and me, Seattle city attorney Pete Holmes and King County prosecutor Dan Satterberg decided to allow us to distribute levamisole test kits—and collect data about whether people are finding levamisole—without prosecution. They notified new Seattle police chief John Diaz, who supports the program. The levamisole test kits will be available in a few weeks—watch for updates in The Stranger and on Slog.
This piece is the first in an investigative series. This story has been updated since its original publication. Most Popular in Features. Why we kiss, give flowers, write cards, and draw hearts. By Rich Smith. How to spend Valentine's Day with a person who's growing another person inside of them. By Leilani Polk.
It's my favorite way to get through the winter. By Chase Burns.
Levamisole Dewormer Fish
Our annual cavalcade of blunders, typos, and errors in judgment. By Stranger Staff. So you've sexually harassed someone.
By. Celebrate this Valentine's Day by becoming a lesbian. By Judy Berry. Where to go and what to do to get through another dreary Seattle winter. (First step: inhale.) by Christopher Frizzelle.
Comments are closed.